SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Agouron Pharmaceuticals (AGPH)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: margie who wrote (2127)10/6/1997 6:44:00 AM
From: Henry Niman   of 6136
 
<<I used to own Ligand. Henry Ninman has always stated he knows nothing about
business or investing, and does not give investment advice. His claim to fame is his
expertise as a scientist, not as an investor. Ligand investors have been waiting quite
awhile for this diabetes deal which is coming "any day" now.>>

Although the diabetes deal for LGND was first mentioned by me in February, the announcement date was projected for late 3Q, early 4Q. Recently analysts form Bear Stearns, Lehman Brothers, Hambrecht & Quist, and Roberston Stephens have issued reiterated BUYS on LGND and they all confirm the above announcement timetable. LGND's 4Q began Oct 1.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext